The global Biosimilar Monoclonal Antibodies revenue was US$ 4509.2 million in 2022 and is forecast to a readjusted size of US$ 12960 million by 2029 with a CAGR of 16.0% during the forecast period (2023-2029).

and India Biosimilar Monoclonal Antibodies Market

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies.

Biosimilar Monoclonal Antibodies refer to the biologic medical product that are almost an identical copy of the original monoclonal antibodies but manufactured by a different company.

In India, the Biosimilar Monoclonal Antibodies revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Global Biosimilar Monoclonal Antibodies key players include Celltrion, 3SBIO, Pfizer (Hospira), Novartis (Sandoz), etc. Global top four manufacturers hold a share nearly 85%.

Europe is the largest market, with a share about 40%, followed by China, and United States, both have a share about 50 percent.

In terms of product, Infliximab is the largest segment, with a share nearly 40%. And in terms of application, the largest application is Autoimmune Disease, followed by Oncology, etc.

This report focuses on global and India Biosimilar Monoclonal Antibodies market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Biosimilar Monoclonal Antibodies will continue to grow rapidly in the future.

Global Biosimilar Monoclonal Antibodies Scope and Market Size

Biosimilar Monoclonal Antibodies market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Biosimilar Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Biosimilar Monoclonal Antibodies market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Biosimilar Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	and India Biosimilar Monoclonal Antibodies Market
Forecasted market size in 2029	US$ 12960 million
CAGR	16.0%
Forecasted years	2023 - 2029
Segment by Type	Infliximab Rituximab Trastuzumab Adalimumab Other
Segment by Application	Oncology Autoimmune Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy’s, Celgen Biopharma, Cadila Healthcare, Hisun Pharma, Torrent Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Biosimilar Monoclonal Antibodies Market size in 2029?

Ans: The and India Biosimilar Monoclonal Antibodies Market size in 2029 will be US$ 12960 million.

What is the market share of major companies in and India Biosimilar Monoclonal Antibodies Market?

Ans: Global top four manufacturers hold a share nearly 85%.

What is the and India Biosimilar Monoclonal Antibodies Market share by type?

Ans: In terms of product, Infliximab is the largest segment, with a share nearly 40%.

What is the and India Biosimilar Monoclonal Antibodies Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Biosimilar Monoclonal Antibodies Market report?

Ans: The main players in the and India Biosimilar Monoclonal Antibodies Market are Celltrion, Pfizer (Hospira), 3SBIO, Novartis (Sandoz), Dr Reddy’s, Celgen Biopharma, Cadila Healthcare, Hisun Pharma, Torrent Pharmaceuticals

What are the Application segmentation covered in the and India Biosimilar Monoclonal Antibodies Market report?

Ans: The Applications covered in the and India Biosimilar Monoclonal Antibodies Market report are Oncology, Autoimmune Disease, Other

What are the Type segmentation covered in the and India Biosimilar Monoclonal Antibodies Market report?

Ans: The Types covered in the and India Biosimilar Monoclonal Antibodies Market report are Infliximab, Rituximab, Trastuzumab, Adalimumab, Other

1 Study Coverage

1.1 Biosimilar Monoclonal Antibodies Product Introduction

1.2 Global Biosimilar Monoclonal Antibodies Outlook 2018 VS 2022 VS 2029

1.2.1 Global Biosimilar Monoclonal Antibodies Sales in US$ Million for the Year 2018-2029

1.2.2 Global Biosimilar Monoclonal Antibodies Sales in Volume for the Year 2018-2029

1.3 India Biosimilar Monoclonal Antibodies Outlook 2018 VS 2022 VS 2029

1.3.1 India Biosimilar Monoclonal Antibodies Sales in US$ Million for the Year 2018-2029

1.3.2 India Biosimilar Monoclonal Antibodies Sales in Volume for the Year 2018-2029

1.4 Biosimilar Monoclonal Antibodies Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Biosimilar Monoclonal Antibodies in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Biosimilar Monoclonal Antibodies Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Biosimilar Monoclonal Antibodies Market Dynamics

1.5.1 Biosimilar Monoclonal Antibodies Industry Trends

1.5.2 Biosimilar Monoclonal Antibodies Market Drivers

1.5.3 Biosimilar Monoclonal Antibodies Market Challenges

1.5.4 Biosimilar Monoclonal Antibodies Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Biosimilar Monoclonal Antibodies by Type

2.1 Biosimilar Monoclonal Antibodies Market Segment by Type

2.1.1 Infliximab

2.1.2 Rituximab

2.1.3 Trastuzumab

2.1.4 Adalimumab

2.1.5 Other

2.2 Global Biosimilar Monoclonal Antibodies Market Size by Type

2.2.1 Global Biosimilar Monoclonal Antibodies Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Biosimilar Monoclonal Antibodies Market Size by Type

2.3.1 India Biosimilar Monoclonal Antibodies Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Biosimilar Monoclonal Antibodies by Application

3.1 Biosimilar Monoclonal Antibodies Market Segment by Application

3.1.1 Oncology

3.1.2 Autoimmune Disease

3.1.3 Other

3.2 Global Biosimilar Monoclonal Antibodies Market Size by Application

3.2.1 Global Biosimilar Monoclonal Antibodies Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Biosimilar Monoclonal Antibodies Market Size by Application

3.3.1 India Biosimilar Monoclonal Antibodies Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Biosimilar Monoclonal Antibodies Competitor Landscape by Company

4.1 Global Biosimilar Monoclonal Antibodies Market Size by Company

4.1.1 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Ranked by Revenue (2022)

4.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer (2018-2023)

4.1.3 Global Biosimilar Monoclonal Antibodies Sales by Manufacturer (2018-2023)

4.1.4 Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2018-2023)

4.2 Global Biosimilar Monoclonal Antibodies Concentration Ratio (CR)

4.2.1 Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Biosimilar Monoclonal Antibodies in 2022

4.2.3 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Product Offered and Application

4.5 Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Biosimilar Monoclonal Antibodies Market Size by Company

4.7.1 Key Players of Biosimilar Monoclonal Antibodies in India, Ranked by Revenue (2022)

4.7.2 India Biosimilar Monoclonal Antibodies Revenue by Players (2018-2023)

4.7.3 India Biosimilar Monoclonal Antibodies Sales by Players (2018-2023)

5 Global Biosimilar Monoclonal Antibodies Market Size by Region

5.1 Global Biosimilar Monoclonal Antibodies Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Biosimilar Monoclonal Antibodies Market Size in Volume by Region (2018-2029)

5.2.1 Global Biosimilar Monoclonal Antibodies Sales in Volume by Region: 2018-2023

5.2.2 Global Biosimilar Monoclonal Antibodies Sales in Volume Forecast by Region (2024-2029)

5.3 Global Biosimilar Monoclonal Antibodies Market Size in Value by Region (2018-2029)

5.3.1 Global Biosimilar Monoclonal Antibodies Sales in Value by Region: 2018-2023

5.3.2 Global Biosimilar Monoclonal Antibodies Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Biosimilar Monoclonal Antibodies Market Size YoY Growth 2018-2029

6.2 Americas Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Biosimilar Monoclonal Antibodies Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Biosimilar Monoclonal Antibodies Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Biosimilar Monoclonal Antibodies Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Biosimilar Monoclonal Antibodies Market Size YoY Growth 2018-2029

7.2 EMEA Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Biosimilar Monoclonal Antibodies Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Biosimilar Monoclonal Antibodies Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Biosimilar Monoclonal Antibodies Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Biosimilar Monoclonal Antibodies Market Size YoY Growth 2018-2029

8.2 China Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Biosimilar Monoclonal Antibodies Market Size YoY Growth 2018-2029

9.2 APAC Biosimilar Monoclonal Antibodies Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Biosimilar Monoclonal Antibodies Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Biosimilar Monoclonal Antibodies Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Biosimilar Monoclonal Antibodies Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Biosimilar Monoclonal Antibodies Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Celltrion

10.1.1 Celltrion Company Information

10.1.2 Celltrion Description and Business Overview

10.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered

10.1.5 Celltrion Recent Development

10.2 Pfizer (Hospira)

10.2.1 Pfizer (Hospira) Company Information

10.2.2 Pfizer (Hospira) Description and Business Overview

10.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered

10.2.5 Pfizer (Hospira) Recent Development

10.3 3SBIO

10.3.1 3SBIO Company Information

10.3.2 3SBIO Description and Business Overview

10.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered

10.3.5 3SBIO Recent Development

10.4 Novartis (Sandoz)

10.4.1 Novartis (Sandoz) Company Information

10.4.2 Novartis (Sandoz) Description and Business Overview

10.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered

10.4.5 Novartis (Sandoz) Recent Development

10.5 Dr Reddy’s

10.5.1 Dr Reddy’s Company Information

10.5.2 Dr Reddy’s Description and Business Overview

10.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Dr Reddy’s Biosimilar Monoclonal Antibodies Products Offered

10.5.5 Dr Reddy’s Recent Development

10.6 Celgen Biopharma

10.6.1 Celgen Biopharma Company Information

10.6.2 Celgen Biopharma Description and Business Overview

10.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered

10.6.5 Celgen Biopharma Recent Development

10.7 Cadila Healthcare

10.7.1 Cadila Healthcare Company Information

10.7.2 Cadila Healthcare Description and Business Overview

10.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered

10.7.5 Cadila Healthcare Recent Development

10.8 Hisun Pharma

10.8.1 Hisun Pharma Company Information

10.8.2 Hisun Pharma Description and Business Overview

10.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered

10.8.5 Hisun Pharma Recent Development

10.9 Torrent Pharmaceuticals

10.9.1 Torrent Pharmaceuticals Company Information

10.9.2 Torrent Pharmaceuticals Description and Business Overview

10.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)

10.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered

10.9.5 Torrent Pharmaceuticals Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Biosimilar Monoclonal Antibodies Industry Chain Analysis

11.2 Biosimilar Monoclonal Antibodies Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Biosimilar Monoclonal Antibodies Production Mode & Process

11.4 Biosimilar Monoclonal Antibodies Sales and Marketing

11.4.1 Biosimilar Monoclonal Antibodies Sales Channels

11.4.2 Biosimilar Monoclonal Antibodies Distributors

11.5 Biosimilar Monoclonal Antibodies Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Torrent Pharmaceuticals

List of Tables

Table 1. Biosimilar Monoclonal Antibodies CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Biosimilar Monoclonal Antibodies Market Trends

Table 3. Biosimilar Monoclonal Antibodies Market Drivers

Table 4. Biosimilar Monoclonal Antibodies Market Challenges

Table 5. Biosimilar Monoclonal Antibodies Market Restraints

Table 6. Global Biosimilar Monoclonal Antibodies Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Biosimilar Monoclonal Antibodies Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Biosimilar Monoclonal Antibodies Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Biosimilar Monoclonal Antibodies Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Biosimilar Monoclonal Antibodies Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Biosimilar Monoclonal Antibodies Revenue Share by Manufacturer, 2018-2023

Table 13. Global Biosimilar Monoclonal Antibodies Sales by Manufacturer, (K Units), 2018-2023

Table 14. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturer, 2018-2023

Table 15. Global Biosimilar Monoclonal Antibodies Price by Manufacturer (2018-2023) & (USD/Unit)

Table 16. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2022)

Table 18. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Product Offered and Application

Table 20. Global Key Manufacturers of Biosimilar Monoclonal Antibodies, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Biosimilar Monoclonal Antibodies in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Biosimilar Monoclonal Antibodies Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Biosimilar Monoclonal Antibodies Revenue Share by Players, (2018-2023)

Table 25. India Biosimilar Monoclonal Antibodies Sales by Players, (K Units), (2018-2023)

Table 26. India Biosimilar Monoclonal Antibodies Sales Share by Players, (2018-2023)

Table 27. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Biosimilar Monoclonal Antibodies Sales in Volume by Region (2018-2023) & (K Units)

Table 29. Global Biosimilar Monoclonal Antibodies Sales in Volume Forecast by Region (2024-2029) & (K Units)

Table 30. Global Biosimilar Monoclonal Antibodies Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Biosimilar Monoclonal Antibodies Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Biosimilar Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Biosimilar Monoclonal Antibodies Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Biosimilar Monoclonal Antibodies Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Biosimilar Monoclonal Antibodies Sales in Volume by Country (2018-2023) & (K Units)

Table 36. Americas Biosimilar Monoclonal Antibodies Sales in Volume by Country (2024-2029) & (K Units)

Table 37. EMEA Biosimilar Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Biosimilar Monoclonal Antibodies Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Biosimilar Monoclonal Antibodies Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Biosimilar Monoclonal Antibodies Sales in Volume by Country (2018-2023) & (K Units)

Table 41. EMEA Biosimilar Monoclonal Antibodies Sales in Volume by Country (2024-2029) & (K Units)

Table 42. APAC Biosimilar Monoclonal Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Biosimilar Monoclonal Antibodies Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Biosimilar Monoclonal Antibodies Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Biosimilar Monoclonal Antibodies Sales in Volume by Country (2018-2023) & (K Units)

Table 46. APAC Biosimilar Monoclonal Antibodies Sales in Volume by Country (2024-2029) & (K Units)

Table 47. Celltrion Company Information

Table 48. Celltrion Description and Business Overview

Table 49. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 50. Celltrion Biosimilar Monoclonal Antibodies Product

Table 51. Celltrion Recent Development

Table 52. Pfizer (Hospira) Company Information

Table 53. Pfizer (Hospira) Description and Business Overview

Table 54. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 55. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product

Table 56. Pfizer (Hospira) Recent Development

Table 57. 3SBIO Company Information

Table 58. 3SBIO Description and Business Overview

Table 59. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 60. 3SBIO Biosimilar Monoclonal Antibodies Product

Table 61. 3SBIO Recent Development

Table 62. Novartis (Sandoz) Company Information

Table 63. Novartis (Sandoz) Description and Business Overview

Table 64. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 65. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product

Table 66. Novartis (Sandoz) Recent Development

Table 67. Dr Reddy’s Company Information

Table 68. Dr Reddy’s Description and Business Overview

Table 69. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 70. Dr Reddy’s Biosimilar Monoclonal Antibodies Product

Table 71. Dr Reddy’s Recent Development

Table 72. Celgen Biopharma Company Information

Table 73. Celgen Biopharma Description and Business Overview

Table 74. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 75. Celgen Biopharma Biosimilar Monoclonal Antibodies Product

Table 76. Celgen Biopharma Recent Development

Table 77. Cadila Healthcare Company Information

Table 78. Cadila Healthcare Description and Business Overview

Table 79. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 80. Cadila Healthcare Biosimilar Monoclonal Antibodies Product

Table 81. Cadila Healthcare Recent Development

Table 82. Hisun Pharma Company Information

Table 83. Hisun Pharma Description and Business Overview

Table 84. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 85. Hisun Pharma Biosimilar Monoclonal Antibodies Product

Table 86. Hisun Pharma Recent Development

Table 87. Torrent Pharmaceuticals Company Information

Table 88. Torrent Pharmaceuticals Description and Business Overview

Table 89. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 90. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product

Table 91. Torrent Pharmaceuticals Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Biosimilar Monoclonal Antibodies Customers List

Table 95. Biosimilar Monoclonal Antibodies Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosimilar Monoclonal Antibodies Product Picture

Figure 2. Global Biosimilar Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Biosimilar Monoclonal Antibodies Market Size 2018-2029 (US$ Million)

Figure 4. Global Biosimilar Monoclonal Antibodies Sales 2018-2029 (K Units)

Figure 5. India Biosimilar Monoclonal Antibodies Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Biosimilar Monoclonal Antibodies Market Size 2018-2029 (US$ Million)

Figure 7. India Biosimilar Monoclonal Antibodies Sales 2018-2029 (K Units)

Figure 8. India Biosimilar Monoclonal Antibodies Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Biosimilar Monoclonal Antibodies Market Share in Global, in Volume (K Units) 2018-2029

Figure 10. Biosimilar Monoclonal Antibodies Report Years Considered

Figure 11. Product Picture of Infliximab

Figure 12. Product Picture of Rituximab

Figure 13. Product Picture of Trastuzumab

Figure 14. Product Picture of Adalimumab

Figure 15. Product Picture of Other

Figure 16. Global Biosimilar Monoclonal Antibodies Market Share by Type in 2022 & 2029

Figure 17. Global Biosimilar Monoclonal Antibodies Sales in Value by Type (2018-2029) & (US$ Million)

Figure 18. Global Biosimilar Monoclonal Antibodies Sales Market Share in Value by Type (2018-2029)

Figure 19. Global Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 20. Global Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 21. Global Biosimilar Monoclonal Antibodies Price by Type (2018-2029) & (USD/Unit)

Figure 22. India Biosimilar Monoclonal Antibodies Market Share by Type in 2022 & 2029

Figure 23. India Biosimilar Monoclonal Antibodies Sales in Value by Type (2018-2029) & (US$ Million)

Figure 24. India Biosimilar Monoclonal Antibodies Sales Market Share in Value by Type (2018-2029)

Figure 25. India Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 26. India Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 27. India Biosimilar Monoclonal Antibodies Price by Type (2018-2029) & (USD/Unit)

Figure 28. Product Picture of Oncology

Figure 29. Product Picture of Autoimmune Disease

Figure 30. Product Picture of Other

Figure 31. Global Biosimilar Monoclonal Antibodies Market Share by Application in 2022 & 2029

Figure 32. Global Biosimilar Monoclonal Antibodies Sales in Value by Application (2018-2029) & (US$ Million)

Figure 33. Global Biosimilar Monoclonal Antibodies Sales Market Share in Value by Application (2018-2029)

Figure 34. Global Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 35. Global Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 36. Global Biosimilar Monoclonal Antibodies Price by Application (2018-2029) & (USD/Unit)

Figure 37. India Biosimilar Monoclonal Antibodies Market Share by Application in 2022 & 2029

Figure 38. India Biosimilar Monoclonal Antibodies Sales in Value by Application (2018-2029) & (US$ Million)

Figure 39. India Biosimilar Monoclonal Antibodies Sales Market Share in Value by Application (2018-2029)

Figure 40. India Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 41. India Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 42. India Biosimilar Monoclonal Antibodies Price by Application (2018-2029) & (USD/Unit)

Figure 43. Americas Biosimilar Monoclonal Antibodies Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 44. Americas Biosimilar Monoclonal Antibodies Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 45. Americas Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 46. Americas Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 47. Americas Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 48. Americas Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 49. United States Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. Canada Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. Mexico Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 52. Brazil Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 53. EMEA Biosimilar Monoclonal Antibodies Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 54. EMEA Biosimilar Monoclonal Antibodies Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 55. EMEA Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 56. EMEA Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 57. EMEA Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 58. EMEA Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 59. Europe Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 60. Middle East Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 61. Africa Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 62. China Biosimilar Monoclonal Antibodies Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 63. China Biosimilar Monoclonal Antibodies Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 64. China Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 65. China Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 66. China Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 67. China Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 68. APAC Biosimilar Monoclonal Antibodies Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 69. APAC Biosimilar Monoclonal Antibodies Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 70. APAC Biosimilar Monoclonal Antibodies Sales by Type (2018-2029) & (K Units)

Figure 71. APAC Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Type (2018-2029)

Figure 72. APAC Biosimilar Monoclonal Antibodies Sales by Application (2018-2029) & (K Units)

Figure 73. APAC Biosimilar Monoclonal Antibodies Sales Market Share in Volume by Application (2018-2029)

Figure 74. Japan Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. South Korea Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. China Taiwan Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. Southeast Asia Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 78. India Biosimilar Monoclonal Antibodies Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 79. Biosimilar Monoclonal Antibodies Value Chain

Figure 80. Biosimilar Monoclonal Antibodies Production Process

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles

Figure 83. Bottom-up and Top-down Approaches for This Report

Figure 84. Data Triangulation

Figure 85. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions